Results 41 to 50 of about 15,642,944 (272)

The impact of the human DNA topoisomerase II C-terminal domain on activity [PDF]

open access: yes, 2008
Background Type II DNA topoisomerases (topos) are essential enzymes needed for the resolution of topological problems that occur during DNA metabolic processes.
West, K.L.   +11 more
core   +2 more sources

Binding of two DNA molecules by type II topoisomerases for decatenation [PDF]

open access: yesNucleic Acids Research, 2012
Topoisomerases (topos) maintain DNA topology and influence DNA transaction processes by catalysing relaxation, supercoiling and decatenation reactions. In the cellular milieu, division of labour between different topos ensures topological homeostasis and control of central processes.
Kumar, Rupesh   +4 more
openaire   +2 more sources

PprA contributes to Deinococcus radiodurans resistance to nalidixic acid, genome maintenance after DNA damage and interacts with deinococcal topoisomerases. [PDF]

open access: yesPLoS ONE, 2014
PprA is known to contribute to Deinococcus radiodurans' remarkable capacity to survive a variety of genotoxic assaults. The molecular bases for PprA's role(s) in the maintenance of the damaged D.
Swathi Kota   +4 more
doaj   +1 more source

Kinetic pathways of topology simplification by Type-II topoisomerases in knotted supercoiled DNA [PDF]

open access: yes, 2018
The topological state of covalently closed, double-stranded DNA is defined by the knot type $K$ and the linking-number difference $\\Delta Lk$ relative to unknotted relaxed DNA. DNA topoisomerases are essential enzymes that control the topology of DNA in
Levene, Stephen D.   +5 more
core   +1 more source

Clerocidin interacts with the cleavage complex of Streptococcus pneumoniae topoisomerase IV to induce selective irreversible DNA damage [PDF]

open access: yes, 2006
Clerocidin (CL), a diterpenoid natural product, alkylates DNA through its epoxide moiety and exhibits both anticancer and antibacterial activities. We have examined CLaction in the presence of topoisomerase IV from Streptococcus pneumoniae.
Fisher, LM   +11 more
core   +1 more source

Methanosarcina acetivorans C2A topoisomerase IIIα, an archaeal enzyme with promiscuity in divalent cation dependence. [PDF]

open access: yesPLoS ONE, 2011
Topoisomerases play a fundamental role in genome stability, DNA replication and repair. As a result, topoisomerases have served as therapeutic targets of interest in Eukarya and Bacteria, two of the three domains of life.
Raymond Morales   +3 more
doaj   +1 more source

On the viability of Escherichia coli cells lacking DNA topoisomerase I [PDF]

open access: yes, 2012
Copyright @ 2012 Stockum et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution,
Lloyd, RG   +8 more
core   +1 more source

Structural insights into the DNA topoisomerase II of the African swine fever virus

open access: yesNature Communications
Type II topoisomerases are ubiquitous enzymes that play a pivotal role in modulating the topological configuration of double-stranded DNA. These topoisomerases are required for DNA metabolism and have been extensively studied in both prokaryotic and ...
Jingyuan Cong   +8 more
doaj   +1 more source

Dynamics of DNA Supercoil Relaxation by Type II Topoisomerases [PDF]

open access: yesBiophysical Journal, 2011
Dynamics of DNA supercoil relaxation by type II topoisomerasesQing Shao∗, Laura Finzi∗, and David Dunlap#Dept. of Physics∗ and Cell Biology#, Emory University, Atlanta, GA 30322Type II topoisomerases are some of the main targets of anti-cancer drugs, since they catalyze DNA decatenation and unwinding which is crucial for cell division. A recent crystal
Shao, Qing, Dunlap, David, Finzi, Laura
openaire   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy